Utilisations thérapeutiques d'interleukine–B50 humaine- Brevets EP1897949 (A2)

Utilisations thérapeutiques d'interleukine–B50 humaine

N° de brevet:	EP1897949 (A2)
Date de publication:	2008-03-12
Inventeur(s):	BAZAN FERNANDO J [US];
Demandeur(s):	SCHERING CORP [US];
Classification:	C12N15/24;C07K14/54;C12Q1/68;C07K16/24;C12N5/10;G01N33/68;C12N5/08;A61K38/00;A61K39/395;A61K45/00;C07K16/28;C12N5/06;C12N15/09;C12P21/02;
N° de demande:	EP20070013358 19990920
Numéro(s) de priorité:	EP19990949626 19990920;US19980157749 19980921;US19990131298P 19990427

Purified genes encoding cytokines from a mammal, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding this molecule are provided. Methods of using said reagents and diagnostic kits are also provided.